Education
About Us
Working with TipRanks
Follow Us
Akums Drugs and Pharmaceuticals Limited (IN:AKUMS)
:AKUMS
Total Valuation
Akums Drugs and Pharmaceuticals Limited has a market cap or net worth of ₹76.97B. The enterprise value is ₹70.61B.
Market Cap₹76.97B
Enterprise Value₹70.61B
Share Statistics
Akums Drugs and Pharmaceuticals Limited has 157,393,980 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding157,393,980
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Akums Drugs and Pharmaceuticals Limited’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 9.55%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)9.55%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee5.40M
Profits Per Employee458.14K
Employee Count7,536
Asset Turnover0.99
Inventory Turnover3.62
Valuation Ratios
The current PE Ratio of Akums Drugs and Pharmaceuticals Limited is 23.4. Akums Drugs and Pharmaceuticals Limited’s PEG ratio is -0.00256.
PE Ratio23.4
PS Ratio1.74
PB Ratio2.32
Price to Fair Value2.32
Price to FCF36.67
Price to Operating Cash Flow―
PEG Ratio-0.00256
Income Statement
In the last 12 months, Akums Drugs and Pharmaceuticals Limited had revenue of 40.71B and earned 3.38B in profits. Earnings per share was 22.60.
Revenue40.71B
Gross Profit16.05B
Operating Income3.11B
Pretax Income3.45B
Net Income3.38B
EBITDA5.29B
Earnings Per Share (EPS)22.60
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
Akums Drugs and Pharmaceuticals Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.53
52-Week Price Change-1.98%
50-Day Moving Average444.46
200-Day Moving Average484.54
Relative Strength Index (RSI)67.62
Average Volume (3m)11.50K
Important Dates
Akums Drugs and Pharmaceuticals Limited upcoming earnings date is Jun 1, 2026, Before Open (Confirmed).
Last Earnings DateFeb 5, 2026
Next Earnings DateJun 1, 2026
Ex-Dividend Date―
Financial Position
Akums Drugs and Pharmaceuticals Limited as a current ratio of 2.55, with Debt / Equity ratio of ―
Current Ratio2.55
Quick Ratio1.78
Debt to Market Cap<0.01
Net Debt to EBITDA-0.02
Interest Coverage Ratio10.22
Taxes
In the past 12 months, Akums Drugs and Pharmaceuticals Limited has paid 14.76M in taxes.
Income Tax14.76M
Effective Tax Rate<0.01
Enterprise Valuation
Akums Drugs and Pharmaceuticals Limited EV to EBITDA ratio is 13.34, with an EV/FCF ratio of 36.61.
EV to Sales1.73
EV to EBITDA13.34
EV to Free Cash Flow36.61
EV to Operating Cash Flow15.18
Balance Sheet
Akums Drugs and Pharmaceuticals Limited has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt―
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share₹204.08
Margins
Gross margin is ―, with operating margin of 7.63%, and net profit margin of 8.31%.
Gross Margin―
Operating Margin7.63%
Pretax Margin8.48%
Net Profit Margin8.31%
EBITDA Margin13.00%
EBIT Margin9.23%
Analyst Forecast
The average price target for Akums Drugs and Pharmaceuticals Limited is ₹680.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹680.00
Price Target Upside61.87% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―